0001145549-22-047486.txt : 20220815 0001145549-22-047486.hdr.sgml : 20220815 20220815144407 ACCESSION NUMBER: 0001145549-22-047486 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 EFFECTIVENESS DATE: 20220815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN FUNDS CORPORATE BOND FUND CENTRAL INDEX KEY: 0001553195 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22744 FILM NUMBER: 221164970 BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET, 55TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET, 55TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 0001553195 S000039110 AMERICAN FUNDS CORPORATE BOND FUND C000120242 Class A BFCAX C000120243 Class 529-F-1 COBFX C000120244 Class R-1 RCBAX C000120245 Class R-2 RCBBX C000120246 Class R-3 RCBCX C000120247 Class R-4 RCBDX C000120248 Class R-5 RCBEX C000120249 Class R-6 RCBFX C000120251 Class C BFCCX C000120252 Class F-1 BFCFX C000120253 Class F-2 BFCGX C000120254 Class 529-A COBAX C000120256 Class 529-C COBCX C000120257 Class 529-E COBEX C000148464 Class R-2E RCBGX C000164799 Class R-5E RCBHX C000179949 Class F-3 CFBFX C000189420 Class 529-T TABBX C000189421 Class T TFBBX C000222346 Class 529-F-2 FFBBX C000222347 Class 529-F-3 FBCDX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001553195 XXXXXXXX true false false N-1A true AMERICAN FUNDS CORPORATE BOND FUND 811-22744 0001553195 549300O55Y3YXWYJZX16 6455 Irvine Center Drive Irvine 92618 US-CA US 9499755000 Capital Research and Management Company 6455 Irvine Center Drive Irvine 92618 9499755000 Fund accounting and transaction settlement records N N N-1A 1 Y Alexandra Trower N/A N Francisco G. Cigarroa N/A N James G. Ellis N/A N Karl J. Zeile N/A Y Margaret Spellings N/A N Mary Davis Holt N/A N Merit E. Janow N/A N Mike C. Gitlin N/A Y Nariman Farvardin N/A N Paul S. Williams N/A N Jane M. Scofield N/A 333 South Hope Street 55th Los Angeles 90071 XXXXXX N N N N N N American Funds Distributors, Inc. 8-17168 000006247 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N N AMERICAN FUNDS CORPORATE BOND FUND S000039110 549300O55Y3YXWYJZX16 N 21 0 0 N/A N N N N Revenue sharing split N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Rule 18f-4 (17 CFR 270.18f-4) Y Y N N Capital Research and Management Company 801-8055 000110885 M02M7XSKLMK96MWKNF95 N American Funds Service Company 84-00316 N/A Y N N Refinitiv US LLC 213800HQORQAP68CJJ04 N Six Financial Information AG 506700D369548LQDC335 CH N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Virtu ITG Solutions Network, LLC N/A N Markit North America, Inc. 549300HLPTRASHS0E726 N N State Street Bank and Trust Co. N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Funds Service Company 84-00316 SEC File number Y N N Capital Research and Management Company M02M7XSKLMK96MWKNF95 Y N N American Funds Distributors, Inc. 8-17168 000006247 N/A 0.0 0.000000000000 Goldman Sachs & Co. LLC 8-00129-1 000000361 FOR8UP27PHTHYVLBNG30 759665589.000000000000 Morgan Stanley & Co. LLC 8-15869-1 000008209 9R7GPTSO7KV3UQJZQ078 552099526.000000000000 J.P. Morgan Securities LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 528829021.000000000000 Bank of America, N.A. 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 497984403.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 350131414.000000000000 BNP Paribas N/A N/A R0MUWSFPU8MPRO8K5P83 FR 338388823.000000000000 Wells Fargo Securities, LLC 8-65876-1 000126292 VYVVCKR63DVZZN70PB21 335833467.000000000000 Barclays Bank PLC N/A N/A G5GSEF7VJP5I7OUK5573 GB 266935807.000000000000 Deutsche Bank A.G. N/A N/A 7LTWFZYICNSX8D621K86 DE 236628262.000000000000 RBC Capital Markets LLC 8-45411-1 000031194 549300LCO2FLSSVFFR64 197072145.000000000000 4649797654.000000000000 N 2047448566.000000000000 Uncommitted 1500000000.000000000000 N N N N true INTERNAL CONTROL RPT 2 internalcontrolcbf.htm CBF INTERNAL CONTROL REPORT - 05/31/2022 PDFtoHTML Conversion Output
 
 

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of American Funds Corporate Bond Fund

In planning and performing our audit of the financial statements of American Funds Corporate Bond Fund (the "Fund") as of and for the year ended May 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of May 31, 2022.

This report is intended solely for the information and use of the Board of Trustees of American Funds Corporate Bond Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Los Angeles, California

July 12, 2022

PricewaterhouseCoopers LLP, 601 South Figueroa Street, Los Angeles, CA 90017 T: (213) 356-6000, F: (813) 637 4444, www.pwc.com/us

 

 
 

 

2